Alterations in the fibroblast growth factor receptor 1 (FGFR1) have been linked to the development and progression of several types of cancer, including breast, lung, gastric, bladder, and ovarian cancers, and is associated with poor prognosis and resistance to chemotherapy [1,2,3]. The gene discussed is FGFR1; the disease is ovarian cancer.